Orion Biotechnology Canada Ltd. — Form D

Orion Biotechnology Canada Ltd. of OTTAWA, ONTARIO, Z4, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-23. The offering totals $5.0M, of which $743K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
Theresa FirestoneDirectorToronto, A6
Jason BurkeExecutive OfficerOttawa, Ontario, Z4
Mark GroperExecutive OfficerOttawa, Ontario, Z4
Theresa FirestoneExecutive OfficerToronto, A6
John JussupExecutive OfficerOttawa, Ontario, Z4
Lonnel CoatsDirectorOttawa, A6
Anatolii KlepatskyDirectorOttawa, Ontario, Z4
Anatolii KlepatskyExecutive OfficerOttawa, Ontario, Z4
Jean ForcioneDirectorOttawa, Ontario, Z4
Katie HewittDirectorOttawa, A6
Praveen TyleDirectorEncinitas, CA
Praveen TyleExecutive OfficerEncinitas, CA
Bradford SmithDirectorOttawa, Ontario, Z4
Mark GroperDirectorOttawa, Ontario, Z4
Jason William BurkeExecutive OfficerOttawa, A6
Jean William ForcioneExecutive OfficerOttawa, A6
John William JussupExecutive OfficerOttawa, A6
Anatolii KlepatskyiDirectorOttawa, A6
Mark HechtDirectorOttawa, A6
Rudolf BomDirectorOttawa, A6
Rudolf BomExecutive OfficerOttawa, A6
Anatole Sheila KlepatskyDirectorOttawa, A6
Anatole Sheila KlepatskyExecutive OfficerOttawa, A6
Thomas Sheila HechtDirectorOttawa, A6
Thomas Sheila HechtExecutive OfficerOttawa, A6

Other filings by this issuer (5)

FiledFormOfferingSold
2025-08-26D/A$15.0M$6.8M
2023-03-15D/A$15.0M$9.9M
2021-06-22D/A$15.0M$5.4M
2021-06-15D$15.0M$5.4M
2020-10-09D$605K

More